Cargando…

A Case of Delayed Onset Nephrogenic Systemic Fibrosis After Gadolinium Based Contrast Injection

Nephrogenic systemic fibrosis (NSF) is a rare fibrosing disorder of the skin and joints that occurs in patients with advanced renal insufficiency. This condition is progressive and can be seriously disabling. Gadolinium based contrast agent (GBCA) has been identified as a potential cause of this con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Do, Jong Geol, Kim, Young Bum, Lee, Dae Gu, Hwang, Ji Hye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Academy of Rehabilitation Medicine 2012
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546195/ https://www.ncbi.nlm.nih.gov/pubmed/23342325 http://dx.doi.org/10.5535/arm.2012.36.6.880

Ejemplares similares

Gadolinium and nephrogenic systemic fibrosis: time to tighten practice
por: Mendichovszky, Iosif A., et al.
Publicado: (2007)

Nephrogenic Systemic Fibrosis as a Complication after Gadolinium-Containing Contrast Agents: A Rapid Review
por: Lange, Sandra, et al.
Publicado: (2021)

An Updated Study to Determine Association between Gadolinium-Based Contrast Agents and Nephrogenic Systemic Fibrosis
por: Zhang, Bin, et al.
Publicado: (2015)

Chelation of gadolinium with deferoxamine in a patient with nephrogenic systemic fibrosis
por: Leung, Nelson, et al.
Publicado: (2009)

Nephrogenic systemic fibrosis (NSF): a late adverse reaction to some of the gadolinium based contrast agents
por: Thomsen, Henrik S., et al.
Publicado: (2007)

Gadolinium-based contrast agents, erythropoietin and nephrogenic systemic fibrosis in patients with end-stage renal failure
por: Pieringer, Herwig, et al.
Publicado: (2008)

Gadolinium-induced nephrogenic systemic fibrosis: the rise and fall of an iatrogenic disease
por: Bennett, Charles L., et al.
Publicado: (2012)

Nephrogenic Systemic Fibrosis in Patients with Chronic Kidney Disease after the Use of Gadolinium-Based Contrast Agents: A Review for the Cardiovascular Imager
por: Gallo-Bernal, Sebastian, et al.
Publicado: (2022)

Nephrogenic systemic fibrosis
por: Braverman, Irwin M, et al.
Publicado: (2010)

Nephrogenic systemic fibrosis
por: Madke, Bhushan, et al.
Publicado: (2011)

Nephrogenic systemic fibrosis
por: Koratala, Abhilash, et al.
Publicado: (2017)

Complications of nephrogenic systemic fibrosis following repeated exposure to gadolinium in a man with hypothyroidism: a case report
por: Aggarwal, Arpita, et al.
Publicado: (2011)

Understanding Nephrogenic Systemic Fibrosis
por: Chopra, Tushar, et al.
Publicado: (2012)

NEPHROGENIC SYSTEMIC FIBROSIS: TIME FOR THE REQUIEM?
por: Panda, Saumya
Publicado: (2011)

NEPHROGENIC SYSTEMIC FIBROSIS: CURRENT CONCEPTS
por: Basak, Prasanta, et al.
Publicado: (2011)

Nephrogenic Systemic Fibrosis: Mini-Review
por: Mundim, Juliano Sacramento, et al.
Publicado: (2009)

NEPHROGENIC SYSTEMIC FIBROSIS: A BRIEF REVIEW
por: Waikhom, Rajesh, et al.
Publicado: (2011)

Nephrogenic Systemic Fibrosis Risk and Liver Disease
por: Hanna, Robert F., et al.
Publicado: (2014)

Nephrogenic systemic fibrosis (NSF): the role of tamoxifen
por: Davison, Rachel, et al.
Publicado: (2010)

Nephrogenic systemic fibrosis: A frivolous entity
por: Bhargava, Vinant, et al.
Publicado: (2021)

A moderate response to plasmapheresis in nephrogenic systemic fibrosis
por: Ustuner, Pelin, et al.
Publicado: (2011)

Nephrogenic Systemic Fibrosis in Denmark– A Nationwide Investigation
por: Elmholdt, Tina R., et al.
Publicado: (2013)

Differences in gadolinium retention after repeated injections of macrocyclic MR contrast agents to rats
por: Bussi, Simona, et al.
Publicado: (2017)

10 Years of Nephrogenic Systemic Fibrosis: A Comprehensive Analysis of Nephrogenic Systemic Fibrosis Reports Received by a Pharmaceutical Company from 2006 to 2016
por: Endrikat, Jan, et al.
Publicado: (2018)

NEPHROGENIC SYSTEMIC FIBROSIS: REVIEW OF 408 BIOPSY-CONFIRMED CASES
por: Zou, Zhitong, et al.
Publicado: (2011)

Minimizing Risk of Nephrogenic systemic fibrosis in Cardiovascular Magnetic Resonance
por: Reiter, Theresa, et al.
Publicado: (2012)

Correction: Nephrogenic Systemic Fibrosis in Denmark– A Nationwide Investigation
Publicado: (2014)

Long-Term Evaluation of Gadolinium Retention in Rat Brain After Single Injection of a Clinically Relevant Dose of Gadolinium-Based Contrast Agents
por: Strzeminska, Izabela, et al.
Publicado: (2020)

Two cases of nephrogenic systemic fibrosis after exposure to the macrocyclic compound gadobutrol
por: Elmholdt, Tina Rask, et al.
Publicado: (2010)

Late Onset Nephrogenic Systemic Fibrosis in a Patient with Stage 3 Chronic Kidney Disease: a Case Report
por: Lim, Yu Jeong, et al.
Publicado: (2020)

Biocompatible Polyhydroxyethylaspartamide-based Micelles with Gadolinium for MRI Contrast Agents
por: Jeong, Sang Young, et al.
Publicado: (2010)

Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide
por: Thomsen, Henrik S.
Publicado: (2006)

Photopheresis Provides Significant Long-Lasting Benefit in Nephrogenic Systemic Fibrosis
por: Zhang, Ranran, et al.
Publicado: (2017)

Erythema nodosum masking nephrogenic systemic fibrosis as initial skin manifestation
por: Fuah, Kar Wah, et al.
Publicado: (2017)

Gadolinium contrast agents: Over exposure?
por: Biederman, Robert W, et al.
Publicado: (2016)

Hypersensitivity to Gadolinium-Based Contrast Media
por: Gracia Bara, M. Teresa, et al.
Publicado: (2022)

Fatal Allergic Reaction to Gadolinium Contrast
por: Chalise, Som N, et al.
Publicado: (2023)

Late-onset acute respiratory distress syndrome induced by a gadolinium-based contrast agent
por: Kato, Kazuhiko, et al.
Publicado: (2019)

Nephrogenic adenoma of the ureter
por: Doluoglu, Omer Gokhan, et al.
Publicado: (2012)

Nephrogenic Fibrosing Dermopathy
por: Dhungel, Ashish, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_5oknsdqjk2govlfq6c0atnt6g2